Clinical features of anthracycline‐induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single‐center, retrospective observational study

We investigated the incidence of cardiotoxicity, its risk factors, and the clinical course of cardiac function in patients with malignant lymphoma (ML) who received a cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) regimen. Among all ML patients who received a CHOP regimen with o...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakayama, Takafumi, Oshima, Yoshiko, Kusumoto, Shigeru, Yamamoto, Junki, Osaga, Satoshi, Fujinami, Haruna, Kikuchi, Takaki, Suzuki, Tomotaka, Totani, Haruhito, Kinoshita, Shiori, Narita, Tomoko, Ito, Asahi, Ri, Masaki, Komatsu, Hirokazu, Wakami, Kazuaki, Goto, Toshihiko, Sugiura, Tomonori, Seo, Yoshihiro, Ohte, Nobuyuki, Iida, Shinsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Haematologic Malignancy ‐ Lymphoid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176145/
https://www.ncbi.nlm.nih.gov/pubmed/35845008
http://dx.doi.org/10.1002/jha2.110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176145/
https://www.ncbi.nlm.nih.gov/pubmed/35845008
http://dx.doi.org/10.1002/jha2.110

Ejemplares similares